Buying Tesla Stock? Wait Until You See This...
With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day.
Click Here...
pixel

TARA Insider Trading (Protara Therapeutics)

Insider Ownership Percentage: 45.70%
Insider Buying (Last 12 Months): $5,886,043.71
Insider Selling (Last 12 Months): $689,231.70

Protara Therapeutics Insider Trading History Chart

Protara Therapeutics Share Price & Price History

$14.95
▼ -0.5 (-3.24%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

Protara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/30/2020Opaleye Management Inc.Major ShareholderBuy50,000$16.00$800,000.00  
9/24/2020Opaleye Management Inc.Major ShareholderBuy300,000$16.87$5,061,000.00  
9/22/2020Blaine DavisCFOBuy1,481$16.91$25,043.711,481  
9/14/2020Randall MarshallMajor ShareholderSell2,554$19.40$49,547.60586,074  
9/10/2020Randall MarshallMajor ShareholderSell239$18.00$4,302.00588,154  
9/8/2020Randall MarshallMajor ShareholderSell3,108$18.94$58,865.52598,615  
9/2/2020Randall MarshallMajor ShareholderSell207$20.68$4,280.76601,775  
8/28/2020Randall MarshallMajor ShareholderSell771$22.09$17,031.39601,982  
8/24/2020Randall MarshallMajor ShareholderSell974$23.16$22,557.84607,248  
8/20/2020Randall MarshallMajor ShareholderSell510$24.18$12,331.80608,222  
8/17/2020Randall MarshallMajor ShareholderSell1,548$25.11$38,870.28610,480  
8/14/2020Randall MarshallMajor ShareholderSell700$25.09$17,563.00610,480  
7/29/2020Randall MarshallMajor ShareholderSell2,516$26.42$66,472.72613,197  
7/27/2020Randall MarshallMajor ShareholderSell338$26.08$8,815.04640,610  
7/24/2020Randall MarshallMajor ShareholderSell2,343$26.53$62,159.79641,341  
7/22/2020Randall MarshallMajor ShareholderSell1,372$26.73$36,673.56644,663  
7/20/2020Randall MarshallMajor ShareholderSell4,330$26.79$116,000.70647,615  
7/17/2020Randall MarshallMajor ShareholderSell1,601$26.66$42,682.66647,615  
7/13/2020Randall MarshallMajor ShareholderSell2,145$27.13$58,193.85651,361  
7/10/2020Randall MarshallMajor ShareholderSell2,659$27.41$72,883.19651,361  
See Full Table

SEC Filings (Institutional Ownership Changes) for Protara Therapeutics (NASDAQ:TARA)

83.11% of Protara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Protara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/24/2021Alyeska Investment Group L.P.74,405$1.80M0.0%-62.8%0.664%
2/16/2021Tri Locum Partners LP39,225$0.95M0.3%N/A0.350%
2/16/2021Alyeska Investment Group L.P.74,405$1.80M0.0%-62.8%0.664%
2/16/2021Nuveen Asset Management LLC24,647$0.60M0.0%N/A0.220%
2/16/2021Price T Rowe Associates Inc. MD433,598$10.50M0.0%-3.2%3.867%
2/16/2021Charles Schwab Investment Management Inc.12,060$0.29M0.0%N/A0.108%
2/13/2021American International Group Inc.2,249$54K0.0%+86.5%0.020%
2/12/2021Ikarian Capital LLC649,542$15.73M0.7%-10.1%5.793%
2/11/2021Northern Trust Corp63,212$1.53M0.0%+71.3%0.564%
2/10/2021Renaissance Technologies LLC17,110$0.41M0.0%-54.7%0.153%
2/10/2021Artisan Partners Limited Partnership376,733$9.12M0.0%+27.1%3.360%
2/9/2021Wells Fargo & Company MN13,110$0.32M0.0%-20.8%0.117%
2/9/2021Bank of New York Mellon Corp25,142$0.61M0.0%N/A0.224%
2/5/2021BlackRock Inc.181,888$4.40M0.0%+97.2%1.622%
12/30/2020Deerfield Management Company L.P. Series C782,670$13.17M0.3%+80.9%6.981%
11/16/2020Perceptive Advisors LLC608,544$10.24M0.1%N/A10.388%
11/16/2020Boothbay Fund Management LLC64,683$1.09M0.1%+46.9%1.104%
11/10/2020State Street Corp23,018$0.39M0.0%+26.8%0.393%
11/10/2020TD Asset Management Inc.25,185$0.42M0.0%N/A0.430%
11/5/2020Wells Fargo & Company MN16,563$0.28M0.0%+89.0%0.283%
11/3/2020Cowen AND Company LLC124,171$2.09M0.3%N/A2.120%
8/14/2020Bank of America Corp DE3,536$0.10M0.0%-56.2%0.060%
8/14/2020Ikarian Capital LLC527,964$15.48M1.2%+17.1%9.013%
8/12/2020American International Group Inc.1,233$36K0.0%N/A0.021%
8/12/2020Knott David M3,835$0.11M0.1%+45.5%0.065%
8/7/2020New York State Common Retirement Fund3,200$94K0.0%N/A0.055%
5/18/2020Perceptive Advisors LLC8,543$0.18M0.0%N/A0.146%
5/15/2020Perceptive Advisors LLC8,543$0.18M0.0%N/A0.146%
5/15/2020Ikarian Capital LLC450,772$10.37M0.8%N/A7.715%
5/13/2020DRW Securities LLC133,543$3.07M0.1%N/A2.286%
5/12/2020Citigroup Inc.1,813$43K0.0%N/A0.031%
2/6/2020Victory Capital Management Inc.992$32K0.0%N/A0.178%
Data available starting January 2016

See Full Table
Protara Therapeutics logo
Protara Therapeutics, Inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is based in New York, New York.
Read More

Today's Range

Now: $14.95
$14.81
$15.35

50 Day Range

MA: $16.68
$13.75
$21.81

52 Week Range

Now: $14.95
$12.51
$67.08

Volume

37,836 shs

Average Volume

94,069 shs

Market Capitalization

$167.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Who are the company insiders with the largest holdings of Protara Therapeutics?

Protara Therapeutics' top insider investors include:
  1. Randall Marshall (Major Shareholder)
  2. Blaine Davis (CFO)
  3. Opaleye Management Inc (Major Shareholder)
The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel